Site Members can sign up for company wide alerts
Lawsuit Overview
According to a press release dated August 13, 2007, the complaint charges Northwest Biotherapeutics and certain of its officers and directors with violations of the Exchange Act. Northwest Biotherapeuticsis a development stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to...
You must register (for free) or login to view the entire case.